Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Robert Rissmann;Rissmann

Professor Translational Dermatology

Leiden University

Netherlands

This profile is automatically generated from trusted academic sources.

Google Scholar

.

ORCID

.

LinkedIn

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI

Contact this professor

LinkedIn

Google Scholar

Research Interests

Immunology

30%

Pharmacotherapy

70%

Anti-inflammatory Research

50%

Immunotherapy

40%

Dermatology

30%

Immune Response

30%

Psoriasis

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles15

Mild psoriasis as a suitable model for proof‐of‐mechanism in a phase 1B setting: Results from a double‐blind placebo‐controlled trial with guselkumab

Year:

2025

Similar Alterations of the Stratum Corneum Ceramide Profile in Atopic Dermatitis, Psoriasis, and Ichthyosis: Results from a Systematic Review and Meta-Analysis

Year:

2024

Guselkumab treatment normalizes the stratum corneum ceramide profile and alleviates barrier dysfunction in psoriasis: results of a randomized controlled trial

Year:

2024

The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers

Year:

2024

Lesional Psoriasis is Associated With Alterations in the Stratum Corneum Ceramide Profile and Concomitant Decreases in Barrier Function

Year:

2024

No effect of topical digoxin and furosemide for patients with actinic keratosis

Year:

2023

Anti-interleukin-17A for pityriasis rubra pilaris: catching the psoriasis biologic wave

Year:

2022

A systematic review on disease‐drug‐drug interactions with immunomodulating drugs: A critical appraisal of risk assessment and drug labelling

Year:

2022

OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.

Year:

2022

Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy Volunteers.

Year:

2021

The Human Vulvar Microbiome: A Systematic Review.

Year:

2021

Integrin αvβ6 as a Target for Tumor-Specific Imaging of Vulvar Squamous Cell Carcinoma and Adjacent Premalignant Lesions.

Year:

2021

Intradermal lipopolysaccharide challenge as an acute in vivo inflammatory model in healthy volunteers.

Year:

2021

Commentary on “Investigator brochures for phase I/II trials lack information on the robustness of preclinical safety studies” by Sievers et al.

Year:

2021

Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial.

Year:

2021

Collaborators3

Simon Yona

University College London

UNITED KINGDOM

Koen van der Maaden

Leiden University

NETHERLANDS

Martijn Manson

Karolinska Institutet

SWEDEN

Social connections

How do I reach out?

Sign in for free to see their profile details and contact information.

Meet Kite AI